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Histopathology of breast cancer in relation to age
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Summary Histological reports of 1869 consecutive women with invasive breast cancer have been reviewed to determine whether
histological features of the tumours were related to the patients' age. The patients, treated between 1983 and 1992, were divided into four
groups, based on age. There were 148 aged < 39 years, 355 aged 40-49 years, 984 aged 50-69 years and 382 aged 70 years or more. The
most outstanding finding was the increase in incidence of grade IlIl infiltrating ductal carcinoma in those aged < 39 years (P< 0.0001). Certain
tumour types, in particular lobular, were reported more frequently in the oldest age group. Additionally, there was a significant reduction of
axillary lymph node metastases, vascular invasion and lymphoplasmacytic stromal reaction with increasing age, all of which were
independent of tumour grade. These data suggest that there may be age-related changes in the histology of breast cancer and, in some
cases, less aggressive features in the elderly. However, as the life expectancy of women over the age of 70 may be many years, treatment
should be based on histological prognostic features of the primary tumour rather than age alone.
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There are reports indicating that breast cancer has a relatively
unfavourable prognosis in young women (Jacquemier et al, 1985;
Rosen et al, 1985; Rochefordiere et al, 1993), but is a disease of
good prognosis among the elderly (Rosen et al, 1985). However,
others have suggested that age does not influence the behaviour of
the disease (Schaefer et al, 1984). Relatively few comparative
studies of histological features of breast cancer in the young and
old have been conducted. It has been reported that there is a signif-
icantly lower mean age for patients with medullary carcinoma,
while lobular and mucoid carcinomas are relatively more frequent
in the elderly (Rosen et al, 1985). Intracystic papillary carcinoma
is also found more frequently in older women (Carter et al, 1983).
In addition, it has been suggested that younger women have more
aggressive high-grade tumours than the elderly (Jacquemier et al,
1985; Rosen et al, 1985).
The aim ofthe present investigation was to review a large series
of patients with invasive breast cancer and to analyse a variety of
histopathological findings in relation to age, in order to determine
whether there were any indications of less or more aggressive
features in different age groups.
PATIENTS AND METHODS
The study comprised 1869 women with invasive breast cancer
who were treated consecutively at the Breast Unit, Guy's Hospital,
in the 10-year period 1983-1992. The patients were divided into
four age groups, < 39 years, 40-49 years, 50-69 years and > 70
years. These age groups were selected for the following reasons.
The cut-off age for young women has ranged from 30-45 years in
previous studies (Jacquemier et al, 1985; Rosen et al, 1985; Lee et
al, 1992). We selected 39 years or under, as this gave a group of a
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reasonable size, which was compatible with previous studies. Age
over 70 years is the usual cut-off for considering women to be
elderly. Forty to 49 years was taken as mostly premenopausal and
50-69 years as post-menopausal. As the age group 50-59 years
will include some pre and perimenopausal patients, a comparison
of 50-59 years and 60-69 years was conducted, which showed no
significant differences, and so the two groups were combined.
Patients with bilateral tumours were included only once. In those
with asynchronous tumours, the pathological findings and age at
presentation of the first tumour were included. When the tumours
were synchronous, the pathology of the larger was included.
Pathological reports were reviewed in respect ofhistological type,
tumour grade, presence of vascular invasion (lymphatic and/or
blood vessel), tumour necrosis and degree of stromal lymphoplas-
macytic reaction. The great majority ofcases were reported by one
pathologist (RRM) and the remainder under her close supervision.
Where an axillary clearance had been performed either as part of
a mastectomy or breast conservation therapy, the total number of
lymph nodes and the number of involved nodes was determined.
Axillary clearance was performed on all patients with invasive
carcinoma, stage I, II and operable III, with the exception of some
elderly patients participating in a randomized trial (EORTC 10850).
Other patients who did not have an axillary clearance were those
with inoperable stage III or IV disease. A small number ofpatients
who had their initial or subsequent treatment elsewhere also did not
have an axillary or complete axillary clearance. The tumours were
typed according to the WHO classification (International Histo-
logical Classification of Tumours, 1981). Infiltrating ductal carci-
nomas were graded by the method of Bloom and Richardson
(1957), with modifications as suggested by Elston (1982).
The amount of stromal lymphoplasmacytic reaction was scored
subjectively as absent, mild, moderate or marked (mild=sparse,
usually peripheral infiltrates or widely scattered denser foci;
moderate=denser, usually more uniform infiltrate but less than
in medullary carcinoma; marked=dense, uniform infiltrate as in
medullary carcinoma). Tumour necrosis was also scored subjec-
tively as absent, mild or marked (mild=one or more small but
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Table 1 Distribution of histological type of invasive tumours in relation to age
Age (years)
<39 40-49 50-69 .70
Total 148 355 984 382
Infiltrating ductal 130 (88%) 281 (79%) 748 (76%) 279 (73%)*
Grade 6 (5%) 34 (12%) 97 (13%) 32 (11%)
Grade II 39 (30%) 128 (46%) 368 (49%) 142 (51%)
Grade III 85 (65%) 119 (42%) 283 (38%) 105 (38%)**
Infiltrating lobular 10 (7%) 44 (12%) 131 (13%) 64 (17%)...
Mucinous 1 4 12 12
Medullary 0 4 8 3
Tubular 1 5 18 3
Others (mixed tumours 6 10 67 21
and rare subtypes)
*X2 heterogeneity=14.64, d.f.=3, P=0.002; X2 trend=13.23, d.f.=1, P=0.0003.
**X2 heterogeneity=36.51, d.f.=3, P<0.0001; X2 trend=23.19, d.f.=1,
P=0.0001. ***X2 heterogeneity=25.18, d.f.=3, p<0.0001; %2 trend=19.36,
d.f.=1, P<0.0001. ****X2 heterogeneity=8.19, d.f.=3, P-0.04; x2 trend=5.25,
d.f.=1, P=0.02.
Table 2 Distribution of axillary metastases in relation to age
Age (years)
<39 40-49 50-69 .70
Total 148 355 984 382
Negative 53 141 436 93
Positive 78 (60%) 166 (54%) 406 (48%) 67 (42%)*
1-3 42 100 250 43
> 4 36 66 156 24
Unknown 17 (11%) 48 (14%) 142 (14%) 222 (58%)**
*X2 heterogeneity=12.08, d.f.=3, P=0.007; x2 trend=12.06, d.f.=1, P=0.0005.
**X2 heterogeneity=336.3, d.f.=3, P<0.0001; x2 trend=178.37, d.f.=1,
P<0.0001.
definite foci of necrosis; marked=large, sheet-like areas of
necrosis). Only necrosis within the invasive component of
tumours was assessed. Vascular invasion was reported as present
or absent. No attempt was made to distinguish between lymphatic
and small blood vessel invasion. Vascular invasion was defined
as neoplastic cells identified within an endothelial lined space.
Statistical analysis
The chi-squared test was used to determine statistical differences
between age groups. A multivariate logistical regression was used
to determine independent predictions of age subgroups, using the
STATA software package. A result was considered statistically
significant ifP < 0.05.
RESULTS
There were 148 women aged 39 years and younger (8%); 355
(19%) aged 40-49 years; 984 (53%) aged 50-69 years and 382
(20%) aged 70 years and over. The distribution of different types
of invasive tumours is shown in Table 1. Infiltrating ductal carci-
noma NOS accounted for 77% ofall invasive tumours. Only these
tumours were graded. There was a significant difference between
the groups in terms of patients with infiltrating ductal cancers,
Table 3 Distribution of stromal lymphoplasmacytic reaction in relation to age
Age (years)
<39 40-49 50-69 .70
Total 148 355 984 382
Mild or absent 71 (48%) 218 (61%) 674 (68%) 289 (76%)*
Moderate 54 (36%) 99 (28%) 226 (23%) 75 (20%)
Marked 23 (16%) 38 (11%) 84 (9%) 18 (5%)
*X2 heterogeneity=43.18, d.f.=3, P<0.0001; X2 trend=41.79, d.f.=1, P<0.0001.
Table 4 Distribution of vascular invasion in relation to age
Age (years)
<39 40-49 50-69 >70
Total 148 355 984 382
Absent 88 (60%) 232 (65%) 723 (74%) 278 (73%)
Present 60 (41%) 123 (35%) 261 (27%) 104 (27%)*
*X2 heterogeneity=21.69, d.f.=3, P<0.0001; X2 trend=15.86, d.f.=1, P<0.0001.
which constituted 88% of those aged < 39 years, 79% of those
aged 40-49 years, 76% of those aged 50-69 years and 73%
of those aged > 70 years (%2 heterogeneity = 14.64, d.f. = 3, P =
0.002; X2 trend = 13.23, d.f. = 1, P = 0.0003). Grade III tumours
were significantly more frequent among those aged < 39 years,
constituting 65% of that group (%2 heterogeneity = 36.51, d.f. = 3,
P < 0.0001; %2 trend = 23.19, d.f. = 1, P < 0.0001).
Infiltrating lobular carcinomas showed a gradual increase in
incidence with increasing age and were most common among the
oldest age group (%2 heterogeneity = 25.18, d.f. = 3, P < 0.0001; %2
trend = 19.36, d.f. = 1, P < 0.0001). Similarly, in the oldest age
group, there were more mucinous carcinomas (%2 heterogeneity =
8.19, d.f. = 3, P = 0.04; X2 trend = 5.25, d.f. = 1, P = 0.02). The
majority of tubular and medullary carcinomas were reported in
the 50-69 age group, but this finding did not reach significance.
Table 2 shows that there was a progressive reduction in the inci-
dence of axillary nodal metastases with increasing age (%2 hetero-
geneity = 12.08, d.f. = 3, P = 0.007; X2 trend = 12.06, d.f. = 1, P =
0.0005). This was independent of tumour grade and applied to the
presence of axillary nodal metastases, but not to the total number
ofnodes involved. However, there was a more significant increase
in the number-of patients with unknown axillary nodal status in
the group aged 70 years or over, 222/382 (58%), because of the
use of wide excision and tamoxifen (x2 heterogeneity = 336.3,
d.f. = 3, P < 0.0001).
There was also asignificantreduction in lymphoplasmacytic reac-
tion with increase in age, with mild or absent reaction being seen in
48% ofthose in the youngest age group compared with 76% ofthose
aged 70 years or over (%2 trend = 41.79, d.f. = 1, P < 0.0001), as
shown in Table 3. Similarly, vascular invasion (lymphatic and/or
blood vessel), present in 29% of all cases of invasive tumour,
showed a progressive reduction with increasing age (Table 4).
Among those aged < 39 years, vascular invasion was observed in
41%, but in only 27% oftumours from women in the two oldest age
groups (%2 trend = 15.86, d.f. = 1, P < 0.0001). Although vascular
British Journal ofCancer (1997) 75(4), 593-596 0 CancerResearch Campaign 1997Breast cancerhistology andage 595
Table 5 Distribution of tumour necrosis in relation to age
Age (years)
.39 40-49 50-69 .70
Total 148 355 984 382
Absent 78 (53%) 238 (67%) 682 (69%) 251 (66%)
Mild 50 (34%) 80 (23%) 234 (24%) 92 (24%)
Marked 20 (14%) 37 (10%) 68 (7%) 39 (10%)
X2 heterogeneity = 16.28, d.f. = 3, P = 0.001; X2 trend = 4.73, d.f. = 1,
P= 0.03.
invasion and lymphoplasmacytic reaction were independently
related to patient age, both were also related to tumour grade with
increased lymphoplasmacytic reaction and the presence of vascular
invasion being more frequent in association with grade III tumours.
Tumour necrosis was present in 47% ofcases aged < 39 years, but in
only 34% of those aged 70 years or over (X2 heterogeneity = 16.28,
d.f. = 3, P = 0.001), as shown in Table 5.
In order to determine whether the relationship between lympho-
plasmacytic reaction, vascular invasion, nodal status, necrosis and
age was independent of grade, logistic regression was performed.
In each case, except necrosis, these factors were related indepen-
dently to age. However, these results apply only to the ductal
group, in which grading was performed.
DISCUSSION
Opinions are much divided as to how age relates to both the prog-
nosis and histopathology of breast cancer. For many years, there
has been a widespread impression among clinicians that breast
cancer in younger women is an aggressive disease, whereas among
older women (2 70 years) the disease has a more indolent nature.
This study has, to some extent, supported these ideas. While
tumours known to have an aggressive nature occur in all age
groups, the increased incidence ofgrade III cancers among younger
women does suggest a less favourable prognosis for this age group.
The high incidence of such tumours in the under-40 age group is
in agreement with previous published findings (Jacquemier et al,
1985; Rosen et al, 1985). Coupled with this, there was a higher
incidence of lymph node metastases in this age group, a finding
which was independent of tumour grade. This is in contrast to
another study, which found an increase in lymph node metastases
in the elderly, despite their having fewer grade III tumours (Rosen
et al, 1985). In a further study of age as a determinant of axillary
node involvement (Holmberg et al, 1992), the lowest prevalence
was found in the youngest and oldest age groups with the highest
incidence in women aged 40-59 years.
In the current study, lymph node metastases were less frequent
in the oldest age group, but in those with metastases the total
number of involved nodes did not differ with age. Additionally,
there were significantly more cases in the oldest age group in
which the axillary nodal status was unknown. It has been
suggested that a non-metastasizing variant ofbreast cancer may be
more common in elderly patients (Hunt et al, 1980).
Together with the higher incidence of grade III tumours in the
youngest age group, there was also an increased incidence of
vascular invasion in this group. No attempt was made to differen-
tiate between blood vessel and lymphatic invasion in this study.
When vascular invasion is recorded without separation into these
categories, an incidence of 23-57% has been reported (Pinder et
al, 1994). Our incidence of 29% is well within this range.
An association was also noted between high-grade tumours and
the degree of lymphoplasmacytic reaction. The significance of
lymphoplasmacytic reaction has been debated for many years
(Cutler et al, 1969; Alderson et al, 1971; Rosen et al, 1981a;
Dawson et al, 1982). Although considered by many to be an
expression of host defence reaction and, therefore, indicative of a
favourable prognosis, this has not been confirmed by others. An
increase in lymphoplasmacytic reaction has been associated with
high-grade tumours in some studies (Rosen et al, 1981b; Elston et
al, 1982). In one study, lymphoplasmocytic reaction, although not
ofoverall prognostic significance, was found to be associated with
a more favourable prognosis when considered in relation to grade
III tumours alone (Elston et al, 1982). As it is has been suggested
that the natural killer cells (NK) are less active in premenopausal
women (Kirkham, 1982), it is obviously important to evaluate the
relative prognostic significance of lymphoplasmacytic reaction in
high-grade tumours in patients of different ages.
In agreement with other workers, some tumours of special type,
namely lobular and mucinous, were noted as occuring more
frequently in older age groups (Rosen et al, 1985). In one recent
study, although mucinous carcinomas were found more frequently
in the elderly, lobular carcinomas were less common in this age
group (Stalsberg and Thomas, 1993). Both are associated with a
more favourable prognosis than infiltrating ductal carcinoma NOS.
However, in contrast, medullary carcinoma was not found to be
associated with young age in this study. The number of tumours of
this type, however, is so small that no significance can be drawn
from these findings. The majority of tubular carcinomas was
reported in the 50-69 age group, and it is interesting to note that
most of these were diagnosed since the National Breast Cancer
Screening Programme was instituted in the United Kingdom.
It does appear, therefore, that specific tumour types and patterns
of metastasis associated with a more favourable prognosis are
found more frequently among the elderly. Nevertheless, it remains
clear that invasive breast cancer in any age group requires
adequate treatment in order to achieve maximum survival and,
furthermore, when women 70 years or over are so treated, there is
no increase in morbidity and the 5 year survival rate is similar to
women under 70 years of age (Amsterdam et al, 1987). The find-
ings in this paper do not suggest that breast cancer in the elderly
warrants less aggressive treatment than that for the young.
Although, obviously, the general health, both physical and mental,
of patients should always be considered, treatment options should
be based on histological features of the disease, rather than on the
age of the patient.
REFERENCES
Alderson MR, Hamlin I and Staunton MD (1971) The relative significance of
prognostic factors in breast carcinoma. Br J Cancer 25: 646-650
Amsterdam E, Birkenfield S. Gilad A and Krispin M (1987) Surgery for carcinoma
ofthe breast in women over 70 years of age. JSuirg Oncol 35: 180-183
Bloom HJG and Richardson WW (1957) Histological grading and prognosis in
breast cancer. Br J Concer 11: 359-377
Carter D, Orr SL and Merino ML (1983) Intracystic papillary carcinoma of the
breast. Cancer 52: 14-19
Cutler SJ, Black MM, Mork T, Harei S and Freeman C (1969) Further observations
on prognostic factors in cancers of the female breast. Cancer 24: 653-667
Dawson PJ, Ferguson DJ and Karrison T (1982) The pathologic findings of breast
cancer patients surviving 25 years after radical mastectomy. Cancer 50:
2131-2138
C Cancer Research Campaign 1997 British Journal ofCancer (1997) 75(4), 593-596596 CJ Fisher etal
Elston CW, Gresham GA, Rao GS, Zerbo T, Haybittle SL, Houghton J and Kearney
G (1982) The Cancer Research Campaign (King's/Cambridge) trial for early
breast cancer: clinico-pathological aspects. Br J Cancer 45: 655-669
Holmberg L, Lindgren A, Norden T, Adami H-O and Bergstrom R (1992) Age as a
determinant ofaxillary node involvement in invasive breast cancer. Acta Oncol
31: 533-538
Hunt KE, Fry DE and Bland KI (1980) Breast carcinoma in the elderly patient. Am J
Surg 140: 339-342
Intemational Histological Classification ofTumours (1981) In Histological Typing
ofBreast Tumours. World Health Organization: Geneva
Jacquemier J, Seradour B, Hassoun J and Piana L (1985) Special morphologic
features of invasive mammary carcinomas in women under 40 years of age.
Breast Dis 1: 119-122
Kirkham N (1982) Natural killer (NK) activity in peripheral blood lymphocytes of
patients with benign and malignant breast disease. BrJ Cancer 46: 611-613
Lee CG, McCormick B, Mazumdar M, Vetto J and Borgen PI (1992) Infiltrating
breast carcinoma in patients age 30 years or younger: long term outcome for
life, relapse, and second primary tumours. IntJRadiat Oncol Biol Phys 23:
969-975
Pinder SE, Ellis IO, Galea M, O'Rourke S, Blamey RW and Elston CW (1994)
Pathological prognostic factors in breast cancer III. Vascular invasion:
relationship with recurrence and survival in a large study group with long-term
follow-up. Histopathology 24: 41-47
Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, Durand
JC, Pouillart P, Magdolenat H and Forquet A (1993) Age as prognostic factor
in premenopausal breast carcinoma. Lancet 341: 1039-1043
Rosen PP, Saigo PE, Braun DW, Weathers E and De Paulo A (198la) Predictors of
recurrence in Stage I (TtNOMO) breast carcinoma. Ann Surg 193: 15-25
Rosen PP, Saigo PE, Braun DW, Weathers E and Kinne DW (1981b) Prognosis in
Stage II (TlNIMO) breast cancer. Ann Surg 194: 576-584
Rosen PP, Lesser ML and Kinne DW (1985) Breast carcinoma in the extremes of
age: a comparison ofpatients younger than 35 years and older than 75 years.
J Surg Oncol 28: 90-96
Schaefer G, Rosen PP, Lesser ML, Kinne DW and Beattie EJ Jr (1984) Breast
carcinoma in elderly women: pathology, prognosis and survival. Pathol Annu
19: 195-219
Stalsberg H and Thomas DB (1993) Age distribution ofhistologic types ofbreast
carcinoma. IntJ Cancer 54: 1-7
British Journal ofCancer (1997) 75(4), 593-596 C CancerResearch Campaign 1997